0001567619-21-004126.txt : 20210216
0001567619-21-004126.hdr.sgml : 20210216
20210216185805
ACCESSION NUMBER: 0001567619-21-004126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASAR VINIT K
CENTRAL INDEX KEY: 0001454324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 21641799
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2021-02-15
0
0000722723
HANGER, INC.
HNGR
0001454324
ASAR VINIT K
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
President and CEO
Common Stock
2021-02-15
4
A
0
69705
0
A
797462
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
159982
159982
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2020 and ending on December 31, 2020. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
Includes (i) unvested restricted shares totaling 69,705 shares of stock from an initial grant of 69,705 shares of restricted stock which begins to vest on March 9, 2021; (ii) unvested restricted shares totaling 54,670 shares of stock from an initial grant of 54,670 shares of restricted stock which begins to vest on March 9, 2021; (iii) unvested restricted shares and fully vested shares totaling 66,708 shares of stock from an initial grant of 73,987 shares of restricted stock made on March 8, 2019; (iv) unvested restricted shares and fully vested shares totaling 52,705 shares of stock from an initial grant of 58,456 shares of restricted stock made on March 8, 2019; (v) unvested restricted shares and fully vested shares totaling 64,712 shares of stock from an initial grant of 80,564 shares of restricted stock made on March 9, 2018; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 66,609 shares of stock from an initial grant of 94,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021 (vii) unvested restricted shares and fully vested shares totaling 38,188 shares of stock from an initial grant of 60,000 shares of restricted stock made on April 29, 2016; (viii) unvested restricted shares and fully vested shares totaling 54,232 shares of stock from an initial grant of 67,516 shares of restricted stock made on March 9, 2018; (ix) fully vested shares totaling 65,566 shares of stock from an initial grant of 95,376 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(x) unvested restricted shares and fully vested shares totaling 42,291 shares of stock from an initial grant of 60,000 shares of restricted stock made on March 8, 2017 (xi) fully vested shares totaling 32,807 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; (xii) fully vested shares totaling 13,746 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (xiii) fully vested shares totaling 21,971 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; [continued in next footnote]
(xiv) fully vested shares totaling 14,230 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (xv) fully vested shares totaling 19,638 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (xvi) fully vested shares totaling 11,589 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (xvii) fully vested shares totaling 16,600 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; [continued in next footnote]
and (xviii) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar
2021-02-16